استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

Cipla bets big on weight-loss drug market in India

July 26, 2025

|

Mint Chennai

The patent for Semaglutide is expiring in countries such as India, Canada, and Brazil in 2026

- Jessica Jani

Drugmaker Cipla Ltd anticipates GLP-1 drugs, used for treating type-2 diabetes and obesity, to be a definite new therapy in the Indian market, and is exploring a wider foray, said chief executive Umang Vohra.

"The Indian market is particularly important to us, where we're looking at the whole GLP-1 category and not just Semaglutide alone," Vohra told reporters on Friday after the company declared its June-quarter results.

Semaglutide, a GLP-1 (glucagon-like peptide-1) drug sold under the brand name Wegovy in India by Novo Nordisk, goes off patent in March 2026.

المزيد من القصص من Mint Chennai

Mint Chennai

HC to hear Apple's plea on fine in Dec

Apple is challenging the new penalty math formula in India's competition law.

time to read

1 min

November 27, 2025

Mint Chennai

India’s labour reforms promote inclusion as well as productivity

The codes are designed to work in the interests of our workforce while supporting economic growth

time to read

3 mins

November 27, 2025

Mint Chennai

Flexi-cap funds in focus as smids falter

A silent pivot

time to read

3 mins

November 27, 2025

Mint Chennai

Mint Chennai

States to raise more debt from market

State borrowing through state development loans (SDLs), which had briefly eased in October after a surge earlier in the year, rose again in November as several major states returned to the market with large auctions, according to the latest Reserve Bank of India (RBI) data.

time to read

1 mins

November 27, 2025

Mint Chennai

Sebi eases adviser, analyst's norms

Markets regulator Sebi has relaxed the educational qualification criteria for Investment Advisers (IAs) and Research Analysts (RAs), allowing graduates from any discipline to apply for registration.

time to read

1 min

November 27, 2025

Mint Chennai

Mint Chennai

Fintechs turn fund magnets with cross-border licensing

Funders see growth prospects in central bank's payment aggregator-cross border licensing

time to read

3 mins

November 27, 2025

Mint Chennai

Mint Chennai

Uber India valuation surges amid battle with Ola, Rapido

November funding values shares 41% higher than the previous round in May 2023

time to read

2 mins

November 27, 2025

Mint Chennai

Mint Chennai

MO Alternates launches its maiden private credit fund

The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions

time to read

3 mins

November 27, 2025

Mint Chennai

Taxpayer base soars, but return filings lag sharply: CBDT data

India’s income tax base is growing faster than the number of those conscientiously filing returns, driven by the expanding reach of the tax deducted at source (TDS) system, according to latest data from the central board of direct taxes (CBDT).

time to read

1 min

November 27, 2025

Mint Chennai

Mint Chennai

A new wave of FDI could help the country stare down uncertainty

India-bound investments in future-focused sectors could favour faster economic growth amid shifting geopolitical dynamics

time to read

4 mins

November 27, 2025

Listen

Translate

Share

-
+

Change font size